Cited by 233HER2/EGFR in Cancer ResearchProtein Kinase Regulation and GTPase SignalingPI3K/AKT/mTOR signaling in cancer

A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling

Open access
HATAKEYAMA, Mariko, KIMURA, Shuhei, NAKA, Takashi, KAWASAKI, Takuji, YUMOTO, Noriko, ICHIKAWA, Mio, KIM, Jae-Hoon, SAITO, Kazuki +4 more·2003·Biochemical Journal

Abstract

ErbB tyrosine kinase receptors mediate mitogenic signal cascade by binding a variety of ligands and recruiting the different cassettes of adaptor proteins. In the present study, we examined heregulin (HRG)-induced signal transduction of ErbB4 receptor and found that the phosphatidylinositol 3'-kinase (PI3K)-Akt pathway negatively regulated the extracellular signal-regulated kinase (ERK) cascade by phosphorylating Raf-1 on Ser(259). As the time-course kinetics of Akt and ERK activities seemed to be transient and complex, we constructed a mathematical simulation model for HRG-induced ErbB4 receptor signalling to explain the dynamics of the regulation mechanism in this signal transduction cascade. The model reflected well the experimental results observed in HRG-induced ErbB4 cells and in other modes of growth hormone-induced cell signalling that involve Raf-Akt cross-talk. The model suggested that HRG signalling is regulated by protein phosphatase 2A as well as Raf-Akt cross-talk, and protein phosphatase 2A modulates the kinase activity in both the PI3K-Akt and MAPK (mitogen-activated protein kinase) pathways.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj20021824

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ERBB4 shows evidence of selection in humans, is part of the ERK/MAPK pathway, and negatively regulates ERK via upstream phosphorylation of Raf-1.

    “the neuregulin (NRG) receptor ERBB4, which shows evidence of selection in humans, is part of the ERK/MAPK pathway and negatively regulates ERK via upstream phosphorylation of Raf-1 [76].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
HATAKEYAMA, M., KIMURA, S., NAKA, T., KAWASAKI, T., YUMOTO, N., ICHIKAWA, M., KIM, J.-H., SAITO, K., SAEKI, M., SHIROUZU, M., YOKOYAMA, S., & KONAGAYA, A.
Affiliations
  • RIKEN Genomic Sciences Center, 1-7-22 Suehirocho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan
  • RIKEN (JP)
  • Kyushu Sangyo University (JP)
  • Mount Fuji Research Institute (JP)
  • SPring-8 (JP)
Corresponding author
  • KIMURA, Shuhei
  • YUMOTO, Noriko
  • ICHIKAWA, Mio
  • SAITO, Kazuki
  • SAEKI, Mihoro
  • SHIROUZU, Mikako
  • YOKOYAMA, Shigeyuki
  • KONAGAYA, Akihiko
Venue
Biochemical Journal
Published
2003-07-15
Volume
373
Issue
2
Pages
451-463
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W2007393641
Cited by
233
References
64
Citations by year
2025: 3 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 2 · 2020: 5 · 2019: 6 · 2018: 11 · 2017: 12 · 2016: 9 · 2015: 8 · 2014: 11 · 2013: 10 · 2012: 17
FWCI
6.13
Type
journal article
Language
en
Open access
Locations
  • Biochemical Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
neuregulin-1, ErbB4, ErbB signaling, PI3K/Akt signaling, MAPK/ERK pathway, Raf-1 phosphorylation, protein phosphatase 2A, signal transduction dynamics
MeSH terms
Animals, Computer Simulation, Enzyme Inhibitors, Cricetinae, Kinetics, Ligands, Models, Molecular, Phosphorylation, Proto-Oncogene Proteins, Serine, Tyrosine, Signal Transduction, CHO Cells, Protein Serine-Threonine Kinases, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-raf, Receptor Cross-Talk, Neuregulin-1, Mitogen-Activated Protein Kinases, Proto-Oncogene Proteins c-akt, ErbB Receptors, Receptor, ErbB-4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review